Anticancer Drugs

• Autore principale: O'Boyle, Niamh M (auth)
• Altri autori: Meegan, Mary J (auth)
• Natura: Elettronico Capitolo di libro
• Lingua: inglese
• Pubblicazione: MDPI - Multidisciplinary Digital Publishing Institute 2019
• Soggetti: Chemistry; graphene oxide; indole; androgens; cyclooxygenase-2; cyclooxygenase-1; heteropolysaccharide; drug conjugation; drug delivery; ellipticine; chemical linker; oesophageal cancer; antiproliferative activity; topoisomerase II; ?-lactam; DSD; antibody; topoisomerase inhibitors; magnetic targeting; cisplatin resistance; steroidogenesis; [18F]FDG PET/CT; heterocyclic chemistry; dehydroepiandrosterone; antimitotic; 3-vinylazetidin-2-ones; glioblastoma; and cancer therapy; intestinal mucositis; Combretastatin A-4; metabolism; anti-cancer drugs; maghemite; COX-1 inhibitor; anticancer; CYP17A1; conjugate and hybrid drugs; inflammation; snticancer drugs; P450c17; tumorigenesis; cisplatin; biomarker profiling; cancer drug design; tubulin; cytochrome P450; 5-fluorouracil; prostate cancer; abiraterone; NCI screen; radiation; cancer immunotherapy; microtubule targeted drugs; cancer; treatment resistance
• Accesso online: DOAB: download the publication; DOAB: description of the publication

The past decades have seen major developments in the understanding of the cellular and molecular biology of cancer. Significant progress has been achieved regarding long-term survival for the patients of many cancers with the use of tamoxifen for treatment of breast cancer, treatment of chronic myel...